Dr. Marc Siegel hosts a Doctor Radio segment on next-generation obesity treatment
The SiriusXM show airs at 3:30pm Eastern with a look at where obesity drugs are heading next.
Recap by typeshit. Post by Doctor Radio on X.
See it on X
More peptides
-
Facebook share says the peptides in question were used for muscle growth and healing 
Facebook share says the peptides in question were used for muscle growth and healing
A short Facebook share with no context on who used the peptides, where it happened or what followed.
-
Eli Lilly shares rise 1.89% in after-hours trading Eli Lilly shares rise 1.89% in after-hours trading
Benzinga notes a 1.89% after-hours gain for Lilly stock, with Novo Nordisk also tagged. No further detail on what drove the move.
-
Dr. Mike, a Quest Nutrition partner, talks protein needs for people on GLP-1s Dr. Mike, a Quest Nutrition partner, talks protein needs for people on GLP-1s
Mikhail Varshavski tells Fox News why protein matters, especially for GLP-1 users. He has a paid partnership with Quest Nutrition.
-
DOWNSIZED goes live to answer viewer questions on GLP-1s, Zepbound and Wegovy 
2:07:50
DOWNSIZED goes live to answer viewer questions on GLP-1s, Zepbound and Wegovy
A live Q&A session covering GLP-1 drugs including Zepbound, Wegovy and Foundayo, with the host taking questions from viewers.
-
Institute of Human Anatomy says most GLP-1 overdoses come from dosing mistakes 
peptides typeshitSafetyInstitute of Human Anatomy says most GLP-1 overdoses come from dosing mistakes
The account argues accidental overdoses usually trace back to dosing errors, and links the problem to approved GLP-1 drugs costing over $1,000 a month uninsured.
-
TikTok explainer says most GLP-1 overdoses come from dosing errors, not intent peptides typeshitSafetyTikTok explainer says most GLP-1 overdoses come from dosing errors, not intent
The clip links the mistakes to people turning to other sources when brand GLP-1s ran short or cost over $1,000 a month without insurance.